Multiple sclerosis. Treatment is shifting.
D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000628:therapy*; D010951:Plasma Exchange
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016899:Interferon-beta; D008942:Mitoxantrone